US 7129221
6,11-bicyclic erythromycin derivatives
granted A61PA61P31/04
Quick answer
US patent 7129221 (6,11-bicyclic erythromycin derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61P, A61P31/04